A survey of 'trigger finger' in adults.
A V Bonnici, J D Spencer
https://pubmed.ncbi.nlm.nih.gov/3385301Actively Recruiting
Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID06296017
Effectiveness of Conservative Interventions in the Treatment of Trigger Finger Comparing Extracorporeal Shock Wave Therapy and Splint Therapy
Led by Hacettepe University · Updated on 2025-09-09
54
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness of two common treatments for Trigger Finger, a condition also known as Stenosing Tenosynovitis. This study compares Extracorporeal Shock Wave Therapy (ESWT) and splint therapy to see which works better for patients diagnosed with stage 1 or 2 trigger finger. The study is a randomized controlled trial involving volunteer patients diagnosed at a hand surgery clinic. Participants will be randomly assigned to one of three groups: one receiving only ESWT, another receiving ESWT combined with splint therapy, and the third receiving only splint therapy. ESWT will be applied to the affected finger at 15 Hz frequency, delivering 1000 shock wave impulses at a 2.0 bar level, across five weekly sessions. Splint therapy involves wearing a finger splint that immobilizes the MCP joint continuously for eight weeks. Throughout the study, evaluations will be conducted before treatment, at the end of the eight-week treatment period, and again four weeks post-treatment. Assessments include pain levels measured by a visual analog scale, grip and pinch strength, number of triggering events, functional ability, and treatment satisfaction. The study aims to enroll 54 participants, with 18 in each treatment group, and will monitor outcomes closely to compare the treatments' effects.
CONDITIONS
Brief Title
Effectiveness of Conservative Interventions in the Treatment of Trigger Finger
Who Can Participate
Age: 18Years - 65Years
All Genders
Eligibility Criteria
You may qualify if you...
- Volunteering to participate in the study
- Being between 18 and 65 years old
- Diagnosed with stage 1 or stage 2 trigger finger (Froimson classification)
- Having the language and cognitive skills to answer questionnaires used in the evaluation
You will not qualify if you...
- Being pregnant
- Having an inflammatory disorder
- Having had surgery on the hand or wrist
- Having a neurological disease
- Currently taking NSAIDs, painkillers, or similar medications
- Having De Quervain's tenosynovitis or carpal tunnel syndrome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 8 weeks
Participants receive one of three treatments: Extracorporeal Shock Wave Therapy (ESWT) with 5 sessions one week apart; splint therapy with a trigger finger splint worn throughout the day for 8 weeks; or a combination of ESWT and splint therapy. Treatment aims to improve trigger finger symptoms.
5 weekly visits for ESWT sessions and ongoing splint use for those assigned; assessments before treatment and immediately after 8 weeks
Follow-up
Duration - 4 weeks
Participants are evaluated 4 weeks after the end of treatment to assess lasting effects on trigger finger symptoms.
1 visit (in-person) approximately 4 weeks after treatment ends
Trial Site Locations
Total: 1 location
1
Feray Karademir
Ankara, Ankara, Turkey (Türkiye), 06100
Actively Recruiting
Loading map...
Research Team
F
Feray Karademir
T
Tüzün Fırat
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Pathobiology of the human A1 pulley in trigger finger.
S P Sampson, M A Badalamente, L C Hurst...
https://pubmed.ncbi.nlm.nih.gov/1880372Trigger finger: etiology, evaluation, and treatment.
Al Hasan Makkouk, Matthew E Oetgen, Carrie R Swigart...
https://pubmed.ncbi.nlm.nih.gov/19468879Notta's nodules and trigger digits.
Adrian E Flatt
https://pubmed.ncbi.nlm.nih.gov/17431449Extracorporeal shock wave therapy versus corticosteroid injection in the treatment of trigger finger: a randomized controlled study.
P Yildirim, A Gultekin, A Yildirim...
https://pubmed.ncbi.nlm.nih.gov/26763271